Editorial draft — not for publication yet. Modafinil content needs review by a qualified UK healthcare professional before publication. This page is general information and is not advice about an individual prescription.
In short
Modafinil is a prescription medicine indicated in the UK for adults with excessive sleepiness associated with narcolepsy. It is not a general treatment for anxiety, insomnia, ADHD, studying or tiredness. Important issues include anxiety and insomnia, cardiovascular and psychiatric monitoring, serious rash, interactions, reduced hormonal contraceptive effectiveness and pregnancy risk.
What is Modafinil used for?
The UK product information indicates modafinil for excessive sleepiness associated with narcolepsy in adults, with or without cataplexy. Treatment should be initiated by or under the supervision of a doctor familiar with the condition and reviewed periodically.
- Excessive sleepiness associated with narcolepsy in adults, with or without cataplexy
- Not authorised in UK safety guidance for sleepiness associated with obstructive sleep apnoea or chronic shift-work sleep disorder
- Not a general treatment for insomnia, anxiety, ADHD, studying, weight loss or unexplained fatigue
The MHRA restricted modafinil’s authorised use to narcolepsy after a benefit-risk review. NICE has separate condition-specific advice mentioning modafinil for excessive daytime sleepiness in some people with Parkinson’s disease after reversible causes are excluded; this is a specialist decision.
The NHS says suspected narcolepsy should be assessed, often by a sleep specialist. Modafinil may improve wakefulness but does not cure narcolepsy or guarantee normal alertness or fitness to drive.
How does it work?
Modafinil promotes wakefulness, although its precise mechanism is not fully understood. It may improve daytime alertness in some people with narcolepsy, but it does not replace sleep or treat every cause of tiredness. Some people still experience sleepiness, and insomnia, anxiety, dizziness or blurred vision may affect daily activities.
How to take Modafinil
- Use only the instructions on your own dispensing label and patient leaflet. Your sleep specialist or prescriber must choose the dose and review whether treatment remains suitable.
- Do not take extra tablets, change timing, share modafinil or use medicine prescribed for someone else.
- Tell the prescriber and pharmacist about every medicine, supplement and contraceptive method before starting or changing treatment.
- Keep clinical follow-up appointments for review of benefit, sleepiness, mental health, blood pressure, heart rate and side effects.
Important: Use the instructions on your own prescription or medicine label. Doses and directions can differ between people and products.
Side effects
Common effects
The selected UK product information lists headache as the most frequently reported effect. Insomnia, anxiety, nervousness, dizziness, sleepiness, nausea, palpitations and other effects can also occur.
Get urgent help
Stop at the first sign of rash as the selected product information directs and do not restart; seek urgent medical advice. Call 999 for severe breathing difficulty, collapse, seizure, severe chest pain or immediate risk of harm.
Warnings and interactions
- The selected product information contraindicates use with uncontrolled moderate-to-severe hypertension or cardiac arrhythmias. Cardiovascular assessment and regular blood-pressure and heart-rate monitoring are recommended.
- Modafinil may cause or worsen anxiety, depression, suicidal thoughts or behaviour, mania, psychosis, agitation or aggression. Tell the prescriber about current or previous mental-health conditions.
- The MHRA advises against modafinil during pregnancy. It may reduce hormonal contraception effectiveness; effective contraception is advised during treatment and for two months after stopping.
- Modafinil can cause insomnia, dizziness and blurred vision, and may not restore normal wakefulness. Do not drive if sleepy or impaired; people with narcolepsy must tell DVLA.
- Check all medicines with a pharmacist. Interactions can affect modafinil or other treatment, and the examples in an online article are not a complete interaction check.
Pregnancy and contraception: an important safety warning
The MHRA advises that modafinil should not be used during pregnancy because of a possible increased risk of congenital malformations. It can also reduce the effectiveness of hormonal contraception. Effective contraception is advised during treatment and for two months after stopping; ask a prescriber or contraception specialist which method is appropriate.
If you are pregnant, might be pregnant or planning pregnancy, contact the prescribing specialist promptly. Do not rely on this general page to assess an individual exposure or change your contraception without professional advice.
Sleepiness, treatment review and driving
A modafinil prescription does not guarantee that wakefulness is normal or that driving is safe. The NHS and DVLA advise that people with narcolepsy must notify DVLA. Do not drive or do hazardous tasks if sleepy, dizzy, visually impaired or unable to concentrate, and check current DVLA requirements for your licence.
A sleep specialist should periodically review whether treatment is helping and monitor relevant risks. If sleepiness continues, do not increase the dose yourself; contact the prescribing team.
Modafinil is not an anxiety or insomnia medicine
Modafinil promotes wakefulness; it is not a treatment for insomnia, anxiety, general fatigue, ADHD or studying. Anxiety and insomnia are also recognised adverse effects. If you searched for modafinil because of anxiety, poor sleep or concentration problems, speak with a GP about assessment and suitable care rather than trying to obtain it without a prescription.
The UK product indication is specific to excessive sleepiness associated with adult narcolepsy. MHRA guidance says it is no longer indicated for sleepiness associated with obstructive sleep apnoea or chronic shift-work sleep disorder.
Frequently asked questions
What is modafinil prescribed for in the UK?
UK product information indicates modafinil for excessive sleepiness associated with narcolepsy in adults, with or without cataplexy.
Can modafinil be used for anxiety or insomnia?
It is not a UK treatment for anxiety or insomnia. It promotes wakefulness and may cause or worsen anxiety and insomnia.
Does modafinil affect hormonal contraception?
Yes. The MHRA warns that it may reduce effectiveness. Effective contraception is advised during treatment and for two months after stopping; ask a clinician about a suitable method.
Can I drive while taking modafinil?
Modafinil does not guarantee normal alertness. People with narcolepsy must notify DVLA, and you should not drive if sleepy or impaired.
Explore the detailed modafinil guides
Each guide answers a different practical question. Advice is specific to modafinil and should be checked against your own product leaflet and prescription.
- What is modafinil used for in the UK?
- Modafinil for narcolepsy: benefits, follow-up and driving
- How does modafinil work? Wakefulness and its limits
- Modafinil dosage: product guidance and safe use
- How long does modafinil take to work?
- Modafinil side effects: common effects and what to do
- Serious modafinil side effects: rash, mood and heart symptoms
- Modafinil warnings: who needs extra checks?
- Modafinil interactions with medicines and contraception
- Can you drink alcohol with modafinil?
- Modafinil in pregnancy and breastfeeding: UK safety advice
- Modafinil and contraception: what the UK warning means
- Can you drive while taking modafinil?
- Modafinil dependence and stopping: what to discuss
- Missed modafinil dose or overdose: what to do
- Modafinil alternatives for narcolepsy: treatment questions
- Modafinil for anxiety? UK use, risks and next steps
- Can modafinil help you sleep? Insomnia and UK guidance
- Other uses of modafinil: ADHD, focus, fatigue and sleep disorders
Sources and review
This draft was checked against the sources below on 2 October 2026. It still requires review by a qualified UK healthcare professional review before publication.
- electronic Medicines Compendium: Modafinil 200 mg tablets: Summary of Product Characteristics
- electronic Medicines Compendium: Modafinil 200 mg tablets: patient information leaflet
- NHS: Narcolepsy: symptoms, diagnosis and treatment
- MHRA / GOV.UK: Modafinil: pregnancy and contraception safety advice
- MHRA / GOV.UK: Modafinil: use restricted to narcolepsy
- NICE: Solriamfetol for excessive daytime sleepiness caused by narcolepsy (TA758)
- NICE: Parkinson’s disease in adults: recommendations (NG71)
- DVLA / GOV.UK: Narcolepsy and driving
- DVLA / GOV.UK: Excessive sleepiness and driving
- NHS: Poisoning: when to get emergency help
Editorial status: Clinical review required before publication.